Abstract:

Cardiovascular diseases of atherosclerotic genesis are one of the most actual problems of modern medicine. The purpose was to estimate the efficiency of interventional radiology treatment of stenosis and occlusions of arteria iliaca interna et externa (lat.) with self-extracting sten Jaguar SM

95 patients aged 44-79 years (71 male and 34 female) were included into experiment: during the period of 2005-2007 they were underwent nterventional radiology treatment of occlusion-stenosis arteria iliaca defeat. All patients in group had atherosclerotic genesis of disease Minimal length of stenosis was 10 mm, the longest stenosis - 90 mm

All the stenosis were estimated due to TASC II. 10 patients had stenosis type A$ 39 patients - type D, 36 patients - type C, and 10 patients - type D. Endovascular recanalization failed in 5 cases of type D stenosis, and these patients were sent for traditional surgical treatment n 1 case a complication occurred - artery perforation during pre-dilatation, and such problem demanded implantation of stent-graft Afterimplantation balloon dilatation was performed in 95% cases. All patients had angiographycally confirmed restored blood flow. Clinica estimation and angiographycal inspection were spent within 2 years. The inspection in 30 days showed the efficiency 100% in case of stenotic defeat and 80% in case of occlusion defeat. The success rate in 12 month was 87%, in 2 years - 82%.
 

References 

1.    Liapis C.D., Tzortzis E.A. Advances in the management of iliac artery occlusive disease. А short review. Vasc. Endovascular. Surg. 2004: 38 (6): 541-545.

2.    Gray B.H., Sullivan T.M. Aortoiliac occlusive disease. Surgical versus interventional therapy. Cur. Interv. Cardiol. Rep. 2001;3 (2):109-116.

3.    Adam D.J., Bradbury A.W. TASC II document on the management of peripheral arterial disease. Eur. J. Vasc. Endovasc. Surg. 2007; 33 (1): 1-2.

4.    Dotter C.T., Judkins M.P. Transluminal Treatment of arteriosclerotic obstruction. description of a new technic and a preliminary    report    of    its    application. Circulation. 1964; 30: 654-670.

5.    Gruntzig A., Hopff H. Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author's transl). Dtsch. Med. Wochenschr. 1974; 99 (49): 2502-2511.

6.    Palmaz J.C. et al. Expandable intraluminal graft. А preliminary study. Work in progress. Radiology. 1985;156 (1): 73-77.

7.    Mohler E., Giri J. Management of peripheral arterial disease patients. Comparing the ACC/AHA and TASC II guidelines. Cur. Med. Res. Opin. 2008; 24 (9): 2509-2522.

8.    Bosiers M. et al. Present and future of endovascular SFA treatment. Stents, stent-grafts, drug coated balloons and drug coated stents. J. Cardiovasc. Surg. 2008; 49 (2): 159-165.

9.    Lagana D. et al. Percutaneous treatment of complete chronic occlusions of the superficial femoral artery. Radiol. Med. 2008; 113 (4): 567-577.

10.  O'Sullivan G.J. Endovascular management of aorto-iliac occlusive disease. Abdom. Imaging. 2008; 4: 25.

11.  Tsetis D., Uberoi R. Quality improvement guidelines for endovascular treatment of iliac artery occlusive disease. Cardiovasc. Intervent. Radiol. 2008; 31 (2): 238-245.

12.  Kudo T., Chandra F.A., Aim S.S. Long-term outcomes and predictors of iliac angioplasty with selective stenting. J. Vasc. Surg. 2005; 42 (3): 466-475.

13.  Van Walraven L.A. et al. The use of vascular stents in the treatment of iliac artery occlusion. Int. J. Angiol. 2000; 9 (4): 232-235.'

14.  Carreira J.M. et al. Long-term follow-up of symphony nitinol stents in iliac arteriosclerosis obliterans. Minim. Invasive. Ther. Allied. Technol. 2008; 17 (1): 44-42.

15.  Norgren L. et al. Inter society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 2007; 45: S5-67.

16.  Diehm N. et al. TASC II section E3 on the treatment of acute limb ischemia. Commentary from European interventionists. J. Endovasc. Ther. 2008; 15 (1): 126-128.

17.  Mousa A.Y. et al. Endovascular treatment of iliac occlusive disease. Review and update. Vascular. 2007; 15 (1): 5-11.

18.  Karwowski J., Zarins C.K. Endografting of the abdominal aorta and iliac arteries for occlusive disease. J. Cardiovasc. Surg. 2005; 46 (4): 349-357.

19.  Sasaki Y. et al. Stenting for superficial femoral artery atherosclerotic occlusion. Long-term follow-up results. Heart. Vessels. 2008; 23 (4): 264-270.

20.  Sapoval M.R. et al. Self-expandable stents for the treatment of iliac arter. Am. J. Roentgenol. 1996; 166 (5): 173-1179.

21.  Sixt S. et al. Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification. А single-center experience. J. Endovasc. Ther. 2008; 15 (4): 408-416.

22.  Zana K. et al. Risk of embolism in diagnostic and therapeutic intravascular procedures - in vitro model. Orv. Hetil. 2001; 142 (34): 1837-1841.

23.  Zana K. et al. In vitro evaluation of the embolic risk of diagnostic and therapeutic intravascular procedures. Med. Sci. Monit. 2001; 7 (1): 148-152.

24.  Saratzis A. et al. Pharmacotherapy before and after endovascular repair of abdominal aortic aneurysms. Cur. Vasc. Pharmacol. 2008; 6 (4): 240-249.

25.  Harnek J. et al. Insertion of self-expandable nitinol stents without previous balloon angioplasty reduces restenosis compared with PTA prior to stenting. Cardiovasc. Intervent. Radiol. 2002; 25 (5): 430-436.